Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELECTRA trial of ticagrelor-based de-escalation strategies in acute coronary syndrome
2020-005130-15Phase 3Active
- Sponsor
- Nicolaus Copernicus University
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ticagrelor and aspirin in acute coronary syndrome (ACS) (3 arms), sponsored by Nicolaus Copernicus University. Started Jan 2021; status: active.
02
Drugs
ticagreloraspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2020-005130-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005130-15.